期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
I-123 metaiodobenzylguanidine imaging for predicting ventricular arrhythmia in heart failure patients 被引量:2
1
作者 Weihua Zhou Ji Chen 《The Journal of Biomedical Research》 CAS 2013年第6期460-466,共7页
Compared to antiarrhythmic drugs, implantable cardioverter defibrillator (ICD) leads to a more significant im- provement in preventing ventricular arrhythmia in heart failure patients. However, an important question... Compared to antiarrhythmic drugs, implantable cardioverter defibrillator (ICD) leads to a more significant im- provement in preventing ventricular arrhythmia in heart failure patients. However, an important question has been raised that how to select appropriate patients for ICD therapy. 1-123 metaiodobenzylguanidine (MIBG) planar and SPECT imaging have shown great potentials to predict ventricular arrhythmia in heart failure patients by as- sessing the abnormalities of the sympathetic nervous system. Clinical trials demonstrated that several parameters measured from 1-123 MIBG planar and SPECT imaging, such as heart-to-mediastinum ratio, washout rate, defect score, and innervation/perfusion mismatch, predicted ventricular arrhythmias in heart failure patients. This paper introduces the current practice of ICD therapy and reviews the technical background of 1-123 MIBG planar and SPECT imaging and their clinical data in predicting ventricular arrhythmia. 展开更多
关键词 heart failure ventricular arrhythmia implantable cardioverter defibrillator 1-123 metaiodobenzyl- guanidine (mibg
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部